MXPA05009055A - Metodo para tratar cancer con derivados de acido quinolona carboxilico. - Google Patents
Metodo para tratar cancer con derivados de acido quinolona carboxilico.Info
- Publication number
- MXPA05009055A MXPA05009055A MXPA05009055A MXPA05009055A MXPA05009055A MX PA05009055 A MXPA05009055 A MX PA05009055A MX PA05009055 A MXPA05009055 A MX PA05009055A MX PA05009055 A MXPA05009055 A MX PA05009055A MX PA05009055 A MXPA05009055 A MX PA05009055A
- Authority
- MX
- Mexico
- Prior art keywords
- carboxylic acid
- acid derivatives
- treating cancer
- quinolone carboxylic
- quinolone
- Prior art date
Links
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical class C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Esta invencion se relaciona con un metodo para tratar un desorden hiper proliferativo, que comprende la administracion de una cantidad efectiva de un compuesto de la Formula (I) a un paciente en necesidad del mismo. (ver formula (I)).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45277003P | 2003-03-07 | 2003-03-07 | |
PCT/US2004/007267 WO2004080465A1 (en) | 2003-03-07 | 2004-03-05 | Method of treating cancer with quinolone carboxylic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05009055A true MXPA05009055A (es) | 2005-10-19 |
Family
ID=32990681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05009055A MXPA05009055A (es) | 2003-03-07 | 2004-03-05 | Metodo para tratar cancer con derivados de acido quinolona carboxilico. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20060142295A1 (es) |
EP (1) | EP1603569A1 (es) |
JP (1) | JP2006519845A (es) |
CA (1) | CA2517676A1 (es) |
MX (1) | MXPA05009055A (es) |
WO (1) | WO2004080465A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3027281A2 (en) * | 2013-07-31 | 2016-06-08 | Palama, Ilaria, El | Cancer therapy with silver nanoparticles |
CN109422726B (zh) * | 2017-09-04 | 2022-10-28 | 华东理工大学 | CD47/SIRPα的阻断剂及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4425649A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Neue 1-[4-(Aminomethyl)phenyl] substituierte Chinoloncarbonsäuren |
-
2004
- 2004-03-05 EP EP04737314A patent/EP1603569A1/en not_active Withdrawn
- 2004-03-05 US US10/546,091 patent/US20060142295A1/en not_active Abandoned
- 2004-03-05 JP JP2006507024A patent/JP2006519845A/ja not_active Withdrawn
- 2004-03-05 WO PCT/US2004/007267 patent/WO2004080465A1/en active Application Filing
- 2004-03-05 CA CA002517676A patent/CA2517676A1/en not_active Abandoned
- 2004-03-05 MX MXPA05009055A patent/MXPA05009055A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004080465A1 (en) | 2004-09-23 |
JP2006519845A (ja) | 2006-08-31 |
US20060142295A1 (en) | 2006-06-29 |
CA2517676A1 (en) | 2004-09-23 |
EP1603569A1 (en) | 2005-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004045523A3 (en) | Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders | |
MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
AU2002950217A0 (en) | 8- Hydroxy Quinoline Derivatives | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
PH12013500913A1 (en) | Substituted-quinoxaline-type-piperidine compounds and the uses thereof | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
MXPA05013712A (es) | Derivados de acido propionico, utiles en el tratamiento de trastornos de lipidos. | |
WO2009067397A3 (en) | Treatment for solid tumors | |
HK1085675A1 (en) | Anticancer compounds | |
UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
ZA200901921B (en) | Pyrazolopyrimidine derivative | |
TW200611689A (en) | Cancer chemotherapy | |
MXPA05010020A (es) | Derivados de oxamida. | |
MXPA05009055A (es) | Metodo para tratar cancer con derivados de acido quinolona carboxilico. | |
WO2007092436A3 (en) | Compounds for treating inflammatory disorders, demyelinating disorders and cancers | |
TW200509921A (en) | Alkaline salts | |
MY145122A (en) | Phenylacetic acid derivatives as cox-2 inhibitors | |
WO2005082862A3 (en) | Benzimidazolyl derivatives as kinase inhibitors | |
ATE540920T1 (de) | Aminobenzocycloheptenderivate, verfahren zu deren herstellung und deren verwendung in der therapie | |
WO2010075255A3 (en) | Methods for treating or preventing cancer and neurodegenerative diseases | |
WO2007146375A3 (en) | Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer | |
NZ584037A (en) | Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same | |
IL157496A0 (en) | Method for producing d-pantothenic acid and/or salts thereof as additive to animal feed | |
IN2003CH01297A (en) | Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |